Skip to main content
. Author manuscript; available in PMC: 2015 Jan 15.
Published in final edited form as: Drugs (Abingdon Engl). 2015;22(1):35–42. doi: 10.3109/09687637.2014.970515

Table 3.

Bivariate associations between self-reported Hepatitis C virus (HCV) positivity and socio-demographic and behavioural characteristics among 162 young IDUs.

Variable Total
n = 162 % (n)
HCV positive
n = 50 % (n)
HCV negative
n = 112 % (n)
Unadjusted IRR
Socio-demographic characteristics
 Site (LA) 47.5 (77) 36.0 (18) 52.7 (59) 0.62 (0.39–1.01)
 Age, mean (SD) 21.35 (2.2) 21.8 (2.1) 21.1 (2.3) 1.11 (1.00–1.22)
 Sex at birth (Female) (n = 161) 36.0 (58) 38.8 (19) 34.8 (39) 1.12 (0.69–1.81)
 Race (White) (n = 161) 63.4 (102) 74.0 (37) 58.6 (65) 1.65 (0.95–2.84)
 Sexual identity (Heterosexual) 65.4 (106) 74.0 (37) 61.6 (69) 0.67 (0.39–1.15)
 Poor/working class growing up (n = 161) 49.7 (80) 60.0 (30) 45.0 (50) 1.52 (0.94–2.44)
 Completed high school 63.0 (102) 56.0 (28) 66.1 (74) 0.75 (0.47–1.19)
 Lifetime homelessness 94.4 (153) 96.0 (48) 93.8 (105) 1.41 (0.41–4.92)
History of institutionalization
 Incarceration 85.2 (138) 92.0 (46) 82.1 (92) 2.00 (0.79–5.05)
 Drug treatment 68.5 (111) 76.0 (38) 65.2 (73) 1.45 (0.83–2.55)
 Psychiatric hospital 49.4 (80) 52.0 (26) 48.2 (54) 1.11 (0.70–1.76)
Lifetime prescribed use
 Opioids 82.7 (134) 84.0 (42) 82.1 (92) 1.10 (0.58–2.08)
 Tranquilizers 58.6 (95) 66.0 (33) 55.4 (62) 1.37 (0.83–2.25)
 Stimulants 52.5 (85) 46.0 (23) 55.4 (62) 0.77 (0.49–1.23)
Lifetime drug using behaviours
 Sniffed PO 81.5 (132) 78.0 (39) 83.0 (93) 0.81 (0.47–1.38)
 Smoked PO 24.7 (40) 18.0 (9) 27.7 (31) 0.67 (0.36–1.26)
 Injected PO 72.2 (117) 92.0 (46) 63.4 (71) 4.42 (1.69–11.61)**
 PO as substitute for heroin 65.4 (106) 88.0 (44) 55.4 (62) 3.87 (1.76–8.55)***
 Injected Heroin (n = 161) 87.0 (140) 94.0 (47) 83.8 (93) 2.35 (0.80–6.90)
 Cocaine (n = 161) 68.3 (110) 88.0 (44) 59.5 (66) 3.40 (1.55–7.48)**
 1st injection – heroin (n = 155) 57.4 (89) 63.3 (31) 54.7 (58) 1.28 (0.78–2.08)
 1st injection – PO 14.8 (24) 18.0 (9) 13.4 (15) 1.26 (0.71–2.25)
 Age of 1st misuse of PO 14.6 (2.49) 14.4 (2.2) 14.7 (2.6) 0.96 (0.88–1.05)
 Age of 1st injection of any drug (n = 156) 17.6 (6.3) 16.4 (2.2) 18.2 (7.4) 0.89 (0.83–0.96)**
 Age of 1st PO injection (n = 117) 18.0 (2.59) 17.7 (2.8) 18.2 (2.5) 0.96 (0.88–1.05)
 Duration of PO injection in years (n = 117) 3.4 (2.7) 4.1 (2.6) 2.9 (2.8) 1.10 (1.03–1.17)**
HCV testing (self-report)
 Age of HCV+ diagnosis 19.1 (2.5)
***

p<0.001,

**

p<0.01,

p<0.10.